Solitary fibrous tumors (SFTs) are rare mesenchymal tumors. Here, we describe the identification of a NAB2-STAT6 fusion from whole-exome sequencing of 17 SFTs. Analysis in 53 tumors confirmed the presence of 7 variants of this fusion transcript in 29 tumors (55%), representing a lower bound for fusion frequency at this locus and suggesting that the NAB2-STAT6 fusion is a distinct molecular feature of SFTs.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
BMC Neurology Open Access 01 December 2022
Surgical Case Reports Open Access 02 August 2022
Cellular and Molecular Life Sciences Open Access 21 July 2022
Subscribe to Journal
Get full journal access for 1 year
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Mertens, F. et al. Semin. Oncol. 36, 312–323 (2009).
Svaren, J. et al. Mol. Cell. Biol. 16, 3545–3553 (1996).
Bhattacharyya, S. et al. PLoS ONE 4, e7620 (2009).
Shimoyamada, H. et al. Am. J. Pathol. 177, 70–83 (2010).
Abdulkadir, S.A. et al. Hum. Pathol. 32, 935–939 (2001).
Pal, N.R., Aguan, K., Sharma, A. & Amari, S. BMC Bioinformatics 8, 5 (2007).
Hebenstreit, D., Wirnsberger, G., Horejs-Hoeck, J. & Duschl, A. Cytokine Growth Factor Rev. 17, 173–188 (2006).
Nelson, E.A., Sharma, S.V., Settleman, J. & Frank, D.A. Oncotarget. 2, 518–524 (2011).
Merk, B.C., Owens, J.L., Lopes, M.B., Silva, C.M. & Hussaini, I.M. BMC Cancer 11, 184 (2011).
He, H.J. et al. J. Biol. Chem. 281, 31369–31379 (2006).
Imielinski, M. et al. Cell 150, 1107–1120 (2012).
Hammerman, P.S. et al. Nature 489, 519–525 (2012).
Barbieri, C.E. et al. Nat. Genet. 44, 685–689 (2012).
Pugh, T.J. et al. Nature 488, 106–110 (2012).
Banerji, S. et al. Nature 486, 405–409 (2012).
We are grateful to the individuals with SFT who contributed material for this study. We thank members of the Genomics Platform at the Broad Institute for their technical expertise and M. Abazeed and A. Dulak for critically reviewing the manuscript. This work was conducted as part of the Slim Initiative for Genomic Medicine in the Americas (SIGMA), a project funded by the Carlos Slim Health Institute in Mexico. This work was supported by a Specialized Program of Research Excellence (SPORE) grant in Soft Tissue Sarcoma (P50 CA140146) and a P01 grant (P01CA47179) to S. Singer (MSKCC). J.C. is supported by an American Cancer Society AstraZeneca Postdoctoral Fellowship. A.M.C. is supported by a grant from the Kristen Ann Carr Foundation. M.M. is supported by generous donations from M.B. Zuckerman and Team Dragonfly of the Pan-Mass Challenge. Material was collected under institutional review board (IRB)-approved protocols at the Memorial Sloan-Kettering Cancer Center and the Oregon Health & Science University Biolibrary. All patients provided informed consent.
M.M. is a paid consultant for and equity holder in Foundation Medicine, a genomics-based oncology diagnostics company, and is a paid consultant for Novartis. M.C.H. is a paid consultant for and equity holder in Molecular MD, a molecular diagnostics company, and is a paid consultant for Novartis.
About this article
Cite this article
Chmielecki, J., Crago, A., Rosenberg, M. et al. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet 45, 131–132 (2013). https://doi.org/10.1038/ng.2522
This article is cited by
BMC Neurology (2022)
Surgical Case Reports (2022)
Rare hypervascular pancreatic tumors diagnosed as asynchronous metastases of central nervous system solitary fibrous tumor/hemangiopericytoma
Clinical Journal of Gastroenterology (2022)
Adenofibromatous Solitary Fibrous Tumor: An Unusual Morphologic Variant Occurring in the Sinonasal Tract
Head and Neck Pathology (2022)